← Association for Accessible Medicines
FDANonrulemakingFDA-2017-D-5846

ANDA Submissions – Refuse-to-Receive Standards: Questions & Answers; Draft Guidance for Industry; Availability

RIN
—
Last modified
Dec 8, 2017
Comment window
closed 3158d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Dec 8, 2017 and Dec 8, 2017. 0 other organizations filed here. The comment window closed 3158d ago.

What Association for Accessible Medicines filed (1)

Dec 8, 2017· Comment from Association for Accessible Medicines· FDA-2017-D-5846-0014

The Association for Accessible Medicines (AAM) acknowledges the efforts of the FDA on Docket Number FDA-2017-D-5846 concerning Refuse-to-Receive (RTR) Standards: Questions and Answesr. We would also like to thank you for the opportunity to share our thoughts on this important public health issue.

View on regulations.gov →

Abstract

No abstract recorded.

View on regulations.gov →

Co-filers (0)

See everyone who commented →